623 related articles for article (PubMed ID: 29290258)
21. Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences.
Oven Ustaalioglu BB; Unal OU; Turan N; Bilici A; Kaya S; Eren T; Ulas A; Inal A; Berk V; Demirci U; Alici S; Bal O; Benekli M; Gumus M
Asian Pac J Cancer Prev; 2013; 14(11):6287-92. PubMed ID: 24377519
[TBL] [Abstract][Full Text] [Related]
22. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
[TBL] [Abstract][Full Text] [Related]
23. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
[TBL] [Abstract][Full Text] [Related]
24. Surgical Results in Pathological N1 Nonsmall Cell Lung Cancer.
Yoshida Y; Yotsukura M; Nakagawa K; Watanabe H; Motoi N; Watanabe SI
Thorac Cardiovasc Surg; 2021 Jun; 69(4):366-372. PubMed ID: 32634835
[TBL] [Abstract][Full Text] [Related]
25. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival.
Fujimoto T; Cassivi SD; Yang P; Barnes SA; Nichols FC; Deschamps C; Allen MS; Pairolero PC
J Thorac Cardiovasc Surg; 2006 Sep; 132(3):499-506. PubMed ID: 16935101
[TBL] [Abstract][Full Text] [Related]
26. Analysis of Patients Unable to Undergo Adjuvant Chemotherapy after Surgery in Stage IIIA/B Non-Small Cell Lung Cancer: Will They Benefit from Mediastinal Radiotherapy?
Graeter TP; Sebastian B; Bischof M; Kugler G; Fischer JR; Schneider T
Thorac Cardiovasc Surg; 2016 Sep; 64(6):501-6. PubMed ID: 26322832
[TBL] [Abstract][Full Text] [Related]
27. Wedge bronchoplastic lobectomy for non-small cell lung cancer as an alternative to sleeve lobectomy.
Park SY; Lee HS; Jang HJ; Joo J; Kim MS; Lee JM; Zo JI
J Thorac Cardiovasc Surg; 2012 Apr; 143(4):825-831.e3. PubMed ID: 22104687
[TBL] [Abstract][Full Text] [Related]
28. Analysis of predictive factors for postoperative survival for non small cell lung carcinoma patients with unexpected mediastinal lymph nodes metastasis.
Wang S; Zhou W; Zhang H; Zhao M; Chen X
Thorac Cardiovasc Surg; 2014 Mar; 62(2):126-32. PubMed ID: 23585223
[TBL] [Abstract][Full Text] [Related]
29. Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer.
Ohtaki Y; Shimizu K; Kaira K; Nagashima T; Obayashi K; Nakazawa S; Kakegawa S; Igai H; Kamiyoshihara M; Nishiyama M; Takeyoshi I
Surg Today; 2016 Oct; 46(10):1196-208. PubMed ID: 26782692
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Factors for Surgically Resected N2 Non-small Cell Lung Cancer.
Kawasaki K; Sato Y; Suzuki Y; Saito H; Nomura Y; Yoshida Y
Ann Thorac Cardiovasc Surg; 2015; 21(3):217-22. PubMed ID: 25641029
[TBL] [Abstract][Full Text] [Related]
31. The Prognostic Significance of Metastasis to Lymph Nodes in Aortopulmonary Zone (Stations 5 and 6) in Completely Resected Left Upper Lobe Tumors.
Citak N; Sayar A; Metin M; Büyükkale S; Kök A; Solak O; Yurt S; Gürses A
Thorac Cardiovasc Surg; 2015 Oct; 63(7):568-76. PubMed ID: 25893919
[TBL] [Abstract][Full Text] [Related]
32. Upstaging and survival after robotic-assisted thoracoscopic lobectomy for non-small cell lung cancer.
Toosi K; Velez-Cubian FO; Glover J; Ng EP; Moodie CC; Garrett JR; Fontaine JP; Toloza EM
Surgery; 2016 Nov; 160(5):1211-1218. PubMed ID: 27665362
[TBL] [Abstract][Full Text] [Related]
33. Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials.
Ichinose Y; Kato H; Koike T; Tsuchiya R; Fujisawa T; Shimizu N; Watanabe Y; Mitsudomi T; Yoshimura M;
Lung Cancer; 2001 Oct; 34(1):29-36. PubMed ID: 11557110
[TBL] [Abstract][Full Text] [Related]
34. Local failure in resected N1 lung cancer: implications for adjuvant therapy.
Higgins KA; Chino JP; Berry M; Ready N; Boyd J; Yoo DS; Kelsey CR
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):727-33. PubMed ID: 22208965
[TBL] [Abstract][Full Text] [Related]
35. Complete thoracic mediastinal lymphadenectomy leads to a higher rate of pathologically proven N2 disease in patients with non-small cell lung cancer.
Cerfolio RJ; Bryant AS; Minnich DJ
Ann Thorac Surg; 2012 Sep; 94(3):902-6. PubMed ID: 22776083
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
[TBL] [Abstract][Full Text] [Related]
37. Is completion lobectomy merited for unanticipated nodal metastases after radical segmentectomy for cT1 N0 M0/pN1-2 non-small cell lung cancer?
Nomori H; Mori T; Izumi Y; Kohno M; Yoshimoto K; Suzuki M
J Thorac Cardiovasc Surg; 2012 Apr; 143(4):820-4. PubMed ID: 22104683
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung.
Riquet M; Manac'h D; Le Pimpec-Barthes F; Dujon A; Chehab A
Ann Thorac Surg; 1999 Jun; 67(6):1572-6. PubMed ID: 10391257
[TBL] [Abstract][Full Text] [Related]
39. Survival following resection of clinically occult N2 non small cell lung cancer.
Dalton R; Keller S
J Cardiovasc Surg (Torino); 1994 Dec; 35(6 Suppl 1):13-7. PubMed ID: 7775526
[TBL] [Abstract][Full Text] [Related]
40. Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer.
Tamura M; Matsumoto I; Saito D; Yoshida S; Takata M; Takemura H
World J Surg Oncol; 2016 Nov; 14(1):295. PubMed ID: 27884195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
